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scientific report
Human immunodeficiency virus 1 (HIV-1) expresses several access-
ory proteins that manipulate various host-cell processes to achieve
optimum replicative efficiency. One of them, viral protein U
(Vpu), has been shown to interfere with the cellular degradation
machinery through interaction with SCFβ-TrCP complexes. To learn
more about Vpu function in vivo, we used the genetically tractable
fruit fly, Drosophila melanogaster. Our results show that the dir-
ected expression of Vpu, but not the non-phosphorylated form,
Vpu2/6, in fat-body cells affects Drosophila antimicrobial responses.
In flies, the Toll and Imd pathways regulate antimicrobial-peptide
gene expression. We show that Vpu specifically affects Toll 
pathway activation by inhibiting Cactus degradation. Given the
conservation of the Toll/nuclear factor-κB (NF-κB) signalling path-
ways between flies and mammals, our results suggest a function
for Vpu in the inhibition of host NF-κB-mediated innate immune
defences and provide a powerful genetic approach for studying
Vpu inhibition of NF-κB signalling in vivo.
EMBO reports 4, 976–981 (2003)
doi:10.1038/sj.embor.embor936
INTRODUCTION
Human immunodeficiency virus 1 (HIV-1) expresses several
accessory proteins that manipulate various host-cell processes to
achieve optimum replicative efficiency and viral pathogenesis.
These factors include the HIV-1 proteins Nef, Vpr, viral protein U (Vpu)
and Vif (Emerman & Malim, 1998). Vpu has been implicated in
targeting CD4, the cellular receptor for HIV-1, for degradation 
by the proteasome. Cell-culture experiments suggest that Vpu 
mediates this targeted degradation through a phosphorylation-
dependent interaction with the F-box/WD40 protein β-TrCP, the
receptor component of the E3 ubiquitin ligase complex SCFβ-TrCP
(Margottin et al., 1998). The Vpu/β-TrCP interaction requires the
phosphorylation of Vpu at a DSGXXS motif, implicating Ser 52
and Ser 56 in this activation (Margottin et al., 1998). This motif is
found in several cellular signalling proteins that are known to be
degraded by the proteasome, such as I-κB-α, the inhibitor of 
the transcription factor nuclear factor-κB (NF-κB; Karin & 
Ben-Neriah, 2000). Recently, it was shown that I-κB-α is a cellular
substrate of β-TrCP (Kroll et al., 1999; Yaron et al., 1998). Bour
and colleagues (2001) showed that Vpu is resistant to β-TrCP-
mediated degradation and that it competitively inhibits β-TrCP-
dependent degradation of I-κB-α in response to tumour necrosis
factor-α (TNF-α), resulting in the suppression of NF-κB activity in
Vpu-expressing cells. In addition, Akari and co-workers (2001)
showed that Vpu inhibits NF-κB-dependent expression of anti-
apoptotic genes, with a consequent activation of the caspase
pathway leading to induction of apoptosis. All these studies were
performed using cell cultures, and the exact in vivo function of
Vpu is not fully understood.
There are striking similarities between the NF-κB signalling
cascades that regulate Drosophila antimicrobial defence
responses and those that regulate vertebrate innate immune
responses. In particular, the Toll and Imd cascades, which regu-
late the expression of antimicrobial-peptide-encoding genes by
the fat body, the functional equivalent of the mammalian liver,
are similar to the mammalian interleukin 1/TLR and TNF receptor
pathways that regulate NF-κB in mammals (Hultmark, 2003).
These parallels prompted us to study the effects of the HIV-1
accessory protein Vpu on Drosophila NF-κB signalling pathways
in vivo. We have used the UAS–Gal4 system to express Vpu and
the non-phosphorylated mutant Vpu2/6, which is incapable of
binding β-TrCP, in flies. Our results show that the directed
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expression of Vpu, but not Vpu2/6, in fat-body cells strongly
affects the Toll pathway, but not the Imd pathway, in response to
microbial infection.
RESULTS
Directed expression of Vpu in fat-body cells
We generated transgenic flies that carry either a UAS–Vpu or a
UAS–Vpu2/6 (S52N/S56N) mutated construct. We crossed the
UAS–Vpu and UAS–Vpu2/6 transgenic flies to flies carrying the
yolk–GAL4 driver, which expresses the yeast transactivator Gal4
in the fat-body cells of female adults. Figure 1A–D shows that flies
carrying both the yolk–GAL4 and UAS–Vpu transgenes express the
Vpu proteins in female adult fat-body cells. As is commonly seen
in human cells (C. Besnard-Guérin, personal communication),
western blot analysis showed that Vpu2/6 is expressed at higher
levels than Vpu and that Vpu migrates more slowly than Vpu2/6
(Fig. 1E, lanes 1 and 3). This difference in gel migration between
Vpu and Vpu2/6 was abrogated when protein extracts were treated
with alkaline phosphatase (Fig. 1E, lane 2). Therefore, in Drosophila
cells, as in human cells, Vpu but not Vpu2/6 is efficiently phos-
phorylated on Ser 52 and Ser 56. Our data indicate that Vpu and
Vpu2/6 are properly expressed and modified in vivo in Drosophila
fat-body cells, which do not show any detectable defects, indicating
that Vpu expression does not affect the physiology of fat-body
cells (Fig. 1C; and data not shown).
Vpu affects Toll-dependent Drosophila immune responses 
We investigated the effect of Vpu expression on the ability of
Drosophila to resist infection by various microbes. Figure 2A
shows that flies expressing Vpu resist infection by the Gram-
negative bacteria Erwinia carotovora at the same level as do
wild-type flies. Figure 2B–D, however, shows that flies express-
ing Vpu, but not Vpu2/6, are more susceptible to fungal infec-
tions than are wild-type flies. This effect is seen after natural
infection by the entomopathogenic fungus Beauveria bassiana
and after direct injection of either Aspergillus fumigatus or
Neurospora crassa spores. This phenotype is similar to, although
slightly weaker than, the fungal susceptibility generated by a null
mutation in spatzle (spz), which encodes the putative ligand of
the Toll receptor (Lemaitre et al., 1996). These results suggest that
Vpu interferes with the Drosophila antifungal immune response.
In Drosophila, resistance to fungal infection is mediated by
the Toll pathway, which controls the expression of genes that
encode peptides with antifungal activities, such as Drosomycin
(Drs) and Metchnikowin (Mtk; Lemaitre et al., 1996; Levashina
et al., 1998). Consequently, we used northern blots to monitor
the expression levels of these two genes in flies that express Vpu
or Vpu2/6 after natural infection with B. bassiana. Figure 3A
shows that natural infection by B. bassiana induced the expres-
sion of Drs and Mtk in wild-type flies and that their expression
was abolished in spz mutants. The induction of the two antifun-
gal-peptide genes, however, was severely impaired in flies
expressing Vpu, but not in flies expressing Vpu2/6 (Fig. 3A).
Resistance to Gram-negative bacterial infections is mediated by
the Imd pathway, which controls the expression of a range of
antibacterial peptide genes, such as Diptericin (Dpt). Figure 3B
shows that Gram-negative bacterial infection induces the
expression of Dpt in wild-type flies and this expression is abol-
ished in dredd mutants. The induction of the Dpt gene was not
affected in Vpu-expressing flies (Fig. 3B). These results show that
expressing Vpu in Drosophila fat-body cells specifically reduces
the induction of antifungal-peptide genes, but not antibacterial
genes, resulting in susceptibility to fungal infection but not to
Gram-negative bacterial infection. This result strongly suggests
that Vpu does not affect general fat-body physiology, but specifi-
cally inhibits the Toll pathway. Next, we tested whether Vpu
blocks the expression of the Drs gene in flies that carry the domi-
nant Toll receptor mutation Tl10B, which constitutively activates
the Toll pathway, thereby generating constitutive Drs and Mtk
expression in the absence of infection (Lemaitre et al., 1996).
Figure 3C shows that Vpu expression completely blocks the Drs
and Mtk expression induced by the Tl10B mutation, whereas
Vpu2/6 expression only affects the Tl10B phenotype slightly. This
suggests a crucial role of Ser 52 and Ser 56 phosphorylation;
however, the slight inhibition of the Toll pathway seen with
Vpu2/6 suggests that Vpu has some effects that are independent
of Ser 52 and Ser 56 phosphorylation. We conclude that Vpu
does not affect the Imd pathway but specifically inhibits the Toll
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Fig. 1 | Viral protein U is expressed and phosphorylated in fat-body cells of
transgenic adult flies. Expression of viral protein U (Vpu) was detected in the
fat-body of UAS–Vpu; yolk–GAL4 females by immunofluorescence (IF)
using an anti-Vpu serum (A–C, visible light; B–D, ultraviolet light).
(A,B) UAS–Vpu flies do not express Vpu in the absence of the yolk–GAL4
driver. A few fat-body cells are indicated with an arrow and have a normal
form. (E) Protein extracts prepared from flies expressing Vpu–HA
(haemagglutinin; lanes 1 and 2) and Vpu2/6–HA (lanes 3 and 4) were
incubated in the presence (lanes 2 and 4) or absence (lanes 1 and 3) of
calf intestinal alkaline phosphatase (CIP) before separation by 
SDS–polyacrylamide gel electrophoresis and analysis by western blotting
using an anti-HA antibody.
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pathway by acting on a component of the cascade that functions
downstream of the Toll receptor.
Vpu blocks the degradation of Cactus
In Drosophila, Toll activates an intracellular signalling pathway
that is mediated by the adaptor molecules Tube and DmMyd88
and by the Pelle kinase. This results in the degradation of the I-κB-α
homologue, Cactus, and the subsequent nuclear translocation of
the NF-κB transcription factors Dorsal and Dif, which control Drs
expression (Belvin & Anderson, 1996; Nicolas et al., 1998;
Tauszig-Delamasure et al., 2002). We tested whether Vpu can
inhibit the Cactus degradation that is induced in cell culture by a
constitutively active form of the Pelle kinase that is encoded by a
Torso–Pelle construct (Galindo et al., 1995; Silverman et al.,
2000). Previous studies showed that in Drosophila S2 cells an
activated form of Toll (Toll∆LRR) induces a Drs–luciferase reporter
gene (Tauszig et al., 2000). Figure 4A shows that expression of
Vpu blocks activation of the Drs–luciferase reporter gene induced
by the expression of Toll∆LRR. This confirms that, as observed 
in vivo, the Toll pathway is a target of Vpu in S2 cells. Figure 4B
shows that expression of Vpu (Fig. 4B, lane 3), but not Vpu2/6 (Fig. 4B,
lane 4), prevents Cactus degradation induced by the expression of
the Torso–Pelle construct (Fig. 4B, lanes 1 and 2). Our data show
that Vpu inhibits Toll-mediated Cactus degradation.
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Fig. 2 | Directed expression of viral protein U makes flies highly susceptible to fungal infections. Directed expression of viral protein U (Vpu) but not Vpu2/6
makes flies susceptible to fungal infection (B–D) but does not affect resistance to Gram-negative bacterial infection (A). Female adults were pricked with a
needle that was previously dipped into (A) a pellet of Erwinia carotovora, or concentrated solutions of spores of (C) Aspergillus fumigatus or (D) Neurospora
crassa, or were naturally infected with Beauveria bassiana (B). The spatzle (spz) gene is required to resist fungal infections (B–D), whereas mutations in dredd
make flies highly susceptible to Gram-negative bacterial infection (A).
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Previous studies have shown that Cactus is phosphorylated on
specific serine residues of the conserved DSGXXS motif that is
present in the amino-terminal part of the Cactus protein (Reach
et al., 1996; Fernandez et al., 2001). In mammals, the regulatory
domain required for human I-κB-α degradation also contains a
DSGXXS motif, suggesting a common mechanism for I-κB-α and
Cactus degradation (Fernandez et al., 2001; Karin & Ben-Neriah,
2000). Bour and colleagues (2001) recently proposed that Vpu,
by binding to β-TrCP through its phosphorylated DSGXXS motif,
interferes with the I-κB-α/β-TrCP interaction. Our in vivo data
that show that Vpu, through its phosphorylated DSGXXS motif,
can interfere with degradation of Cactus in Drosophila, which
supports this hypothesis. We propose that Vpu, by binding to a
homologue of β-TrCP in Drosophila, inhibits Cactus degradation.
Slimb is not involved in Toll pathway activation in adults
Slimb is the closest Drosophila homologue of β-TrCP and regu-
lates protein degradation in several signalling pathways ( Jiang &
Struhl, 1998). It has been shown recently that Slimb is part of a
ubiquitin–proteasome pathway that represses the Imd pathway
(Khush et al., 2002). A null mutation in the slimb gene (slimbm) is
lethal (Grima et al., 2002). We rescued the slimbm mutation dur-
ing development with a heat-shock (hs)–slimb transgene, as
described in Grima et al. (2002), and analysed the response to
fungal infection of adult flies in which the Slimb protein is
depleted. Figure 5 shows that in slimbm mutant flies the Drs gene
is expressed after fungal infection at even higher levels than in
the wild-type flies. We found that Dpt is expressed constitutively
at a low level in unnchallenged slimbm mutant flies (data not
shown), as previously shown (Khush et al., 2002). Although Vpu
expression during larval stages does induce a slimb-mutant-like
phenotype during wing and leg development (B.L.-B., unpub-
lished data), Vpu expression does not have the same effect as the
slimbm mutation on Dpt expression (Fig. 3B). Altogether, our
results show that Slimb is not required for proper Toll pathway
function in the adult stage.
DISCUSSION
We have shown that expressing the HIV-1 accessory protein Vpu
in Drosophila fat-body cells leads to immunocompromised flies:
Vpu inhibits the Toll signalling pathway but not the Imd pathway.
Consequently, flies expressing Vpu do not express antifungal-
peptide genes and are highly susceptible to fungal infection, but
have normal sensitivity to Gram-negative bacterial infections.
Vpu blocks the Toll pathway by interfering with Cactus degrada-
tion. We also show that Slimb, the closest Drosophila homologue
to β-TrCP, is not required for Toll pathway activity in the adult
stage. The latter result contradicts previous studies that showed
that Slimb is required for Toll-dependent activation of twist and
snail in Drosophila embryos (Spencer et al., 1999). The require-
ment of Slimb for Cactus degradation during dorsoventral pat-
terning is, however, controversial, and Fernandez and co-workers
(2001) suggested that Slimb functions early during embryogenesis
and its effect on the Toll pathway might thus be indirect.
Therefore, the target of Vpu in the Cactus-degradation machinery
remains to be identified. Our study suggests that one of the func-
tions of Vpu is to inhibit NF-κB-mediated innate immune
defences. The similarities seen between Vpu inhibition of I-κB-α
and Cactus degradation through its phosphorylated DSGXXS
motif underline the value of Drosophila as a model for determin-
ing the functions of Vpu in regulating innate immune responses.
Furthermore, our results shed light on some differences between
the molecular players in the pathways that regulate NF-κB in
Drosophila and mammals. Recent reports indicate that β-TrCP
also regulates the proteolysis and/or constitutive processing of
the NF-κB1/p105 precursor of p50 (Heissmeyer et al., 2001; Lang
et al., 2003), as well as the inducible processing of the NF-κB2/p100
precursor of p52 (Fong & Sun, 2002). In both cases, a phosphory-
lation motif similar to DSGXXS is required for β-TrCP-mediated
processing of these Rel compound proteins. Interestingly, this
motif is not present in Relish, the third Drosophila Rel protein,
which is a homologue of p100 and p105 (Dushay et al., 1996).
Indeed, Relish requires caspase cleavage, but not proteasomal
partial degradation, for its activation (Stöven  et al., 2000, 2003).
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These marked differences presumably explain why Vpu has no
effect on the Imd pathway that regulates Relish activity in response
to Gram-negative bacterial infection. Thus, the comparison
between the differential effects of Vpu in all NF-κB activation
pathways, both in Drosophila and mammals, might also help in
the understanding of the mechanisms involved in the regulation
of innate immunity in both types of organisms.
Taking into account the crucial contribution of the innate
immune response both to fighting HIV infection and activating
the adaptive immune response, it is clearly advantageous for HIV
to produce a protein that interferes with innate immunity path-
ways. Recently, TLR3 and TLR4 have been implicated in antiviral
responses (Alexopoulou et al., 2001; Doyle et al., 2002).
Therefore, Vpu may inhibit the innate antiviral response activated
by these two receptors, facilitating the proliferation of HIV-1
inside the host. It will be worthwhile to determine whether 
Vpu specifically interferes with the TLR/NF-κB pathway in 
vertebrates, as it does with the TNF-α pathway.
Finally, our study provides an opportunity for using powerful
enhancer and suppressor genetic screens in flies to identify other
host factors that interact with Vpu and, thereby, to gain further
insight into how this protein manipulates basic cellular processes
such as the degradation pathway.
METHODS
Fly stocks.Vpu2/6 is a mutant form of Vpu, in which Ser 52 and Ser 56
have been replaced by asparagine residues. Complementary
DNAs encoding Vpu and Vpu2/6 originate from an HIV-Lai isolate.
They were subcloned into a pUAST plasmid vector with and with-
out a carboxy-terminal haemagglutinin (HA) tag. The same inser-
tions, UAS–Vpu2/6 (X chromosome) and UAS–Vpu (third chromo-
some), were used in all experiments in this study. UAS–Vpu–HA
and UAS–Vpu2/6–HA were used in calf intestinal phosphatase
experiments. CantonS was used as a wild-type strain. Other strains
used have been described elsewhere (Leulier et al., 2000; Grima 
et al., 2002).
Survival assays and northern blot analysis. Survival assays and
northern blot analysis were performed as described in Leulier et al.
(2000). Forty flies were used for survival analysis and the ribosomal
protein rp49 probe was used as a loading control in northern blots.
Immunofluorescence, cell culture and transfection, protein
extractions, western blot analysis, calf intestinal phosphatase
experiments and reporter assays. See supplementary information
online.
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Supplementary information is available at EMBO reports online
(http://www.emboreports.org).
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